US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about immune/mediated diseases
Recent news which mentions immune/mediated diseases
Pioneering Paths Forward in Immunology
July 12, 2022
Tickers
BMY
Tags
Innovation & Technology
NYSE:BMY
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Lupus: Treatments, Research and Bristol Myers Squibb's Dedication to Patients - A Q&A With Subhashis Banerjee
June 06, 2022
Tickers
BMY
Tags
Health & Healthcare
immune/mediated diseases
Subhashish Banerjee
From
3BL Media: Corporate Social Responsibility, Energy and Health News